The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene label mismatch: NRAS vs undefined
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC computed assertion could be determined for this classification!


Variant: NM_002524.5(NRAS):c.112-8A>G

CA292582

138538 (ClinVar)

Gene: NRAS
Condition: RASopathy
Inheritance Mode: Autosomal dominant inheritance
UUID: f78fdf60-318d-46a1-b4c9-1b3f963bb80a
Approved on: 2024-12-03
Published on: 2025-03-26

HGVS expressions

NM_002524.5:c.112-8A>G
NM_002524.5(NRAS):c.112-8A>G
NC_000001.11:g.114713986T>C
CM000663.2:g.114713986T>C
NC_000001.10:g.115256607T>C
CM000663.1:g.115256607T>C
NC_000001.9:g.115058130T>C
NG_007572.1:g.7909A>G
ENST00000369535.5:c.112-8A>G
ENST00000369535.4:c.112-8A>G
NM_002524.4:c.112-8A>G
More

Likely Benign

Met criteria codes 3
BP7 BP4 BS1
Not Met criteria codes 3
BA1 PP3 PM2

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen RASopathy Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for NRAS Version 2.3.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
RASopathy VCEP
The NM_002524.5:c.112-8A>G variant is an intronic variant that is not predicted by SpliceAI to impact splicing. In addition, it occurs at a nucleotide that is not conserved as shown by UCSC Genome Browser (BP4, BP7). The filtering allele frequency (the lower threshold of the 95% CI of 62/127294) of the c.112-8A>G variant in NRAS is 0.0003711 for European (non-Finnish) chromosomes by gnomAD v2.1.1, which is higher than the ClinGen RASopathy VCEP threshold (≥0.00025) for BS1, and therefore meets this criterion (BS1). In summary, this variant meets the criteria to be classified as likely benign for autosomal dominant RASopathy based on the ACMG/AMP criteria applied, as specified by the ClinGen RASopathy VCEP: BS1, BP4, BP7. (ClinGen RASopathy VCEP specifications version 2.3; 12/3/2024)
Met criteria codes
BP7
The NM_002524.5:c.112-8A>G variant is an intronic variant that is not predicted by SpliceAI to impact splicing. In addition, it occurs at a nucleotide that is not conserved as shown by UCSC Genome Browser (BP4, BP7).
BP4
The NM_002524.5:c.112-8A>G variant is an intronic variant that is not predicted by SpliceAI to impact splicing. In addition, it occurs at a nucleotide that is not conserved as shown by UCSC Genome Browser (BP4, BP7).
BS1
The filtering allele frequency (the lower threshold of the 95% CI of 62/127294) of the c.112-8A>G variant in NRAS is 0.0003711 for European (non-Finnish) chromosomes by gnomAD v2.1.1, which is higher than the ClinGen RASopathy VCEP threshold (≥0.00025) for BS1, and therefore meets this criterion (BS1).
Not Met criteria codes
BA1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PP3
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PM2
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.